A Mindfulness-based Intervention for Sexual Assault Survivors

March 31, 2026 updated by: Anne Marie Schipani-McLaughlin, Georgia State University

Leveraging Implementation Science to Develop a Mindfulness-Based Intervention to Reduce Alcohol Misuse and Tobacco Use Among Sexual Violence Survivors

The goal is this pilot randomized trial is to learn if intervention 1 is feasible and acceptable. As a secondary goal, we aim to learn if intervention 1 reduces alcohol misuse and tobacco use in sexual assault survivors. The main questions it aims to answer are:

  • Is intervention 1 feasible to implement?
  • Is intervention 1 an acceptable intervention among the primary population, sexual assault survivors?
  • Does intervention 1 reduce alcohol misuse and tobacco use?

Researchers will compare intervention 1 to an attention-placebo control group (e.g., online resources on healthy eating and nutrition).

Participants will:

  • take online surveys at baseline, 1 month follow-up, and 3-month follow-up
  • answer text-message questions at baseline and post-test
  • view and engage in an educational program

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Anne Marie Schipani, PhD, MPH
  • Phone Number: 404-413-2339
  • Email: aschipani@gsu.edu

Study Contact Backup

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30303
        • Georgia State University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18-24 years of age
  • currently enrolled as a full-time undergraduate at GSU
  • self-reported lifetime SV victimization
  • self-reported SV victimization in the past 6 months
  • drank alcohol within the last 30 days
  • must own a smartphone

Exclusion Criteria:

  • not applicable

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1
intervention 1 is a mindfulness-based intervention that aims to reduce alcohol misuse and tobacco use
A mindfulness-based intervention that aims to reduce alcohol misuse and tobacco use
Other Names:
  • MindfulHeal
Placebo Comparator: Study Arm 2
online resources on healthy eating and nutrition guidelines
online resources on healthy eating and nutrition guidelines

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment and retention of 70% of the sample at 3-month follow-up
Time Frame: 3 month follow-up
Feasibility of the sample is assessed by recruitment and retention of at least 70% participants at 3 month follow-up
3 month follow-up
Acceptability of the mindfulness-based intervention benchmark of 80% self-reported acceptability
Time Frame: immediate post-test
Self-reported assessment of the following domains: quality, usefulness, relevancy, extent to which situations depicted are realistic, extent to which attitudes changed on alcohol and tobacco use, and managing stress
immediate post-test

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol misuse assessed by Timeline Follow-Back Measuring Alcohol Consumption
Time Frame: 3 month follow-up
a 10-item measure of alcohol use with .85 reliability
3 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne Marie Schipani, PhD, MPH, Georgia State University School of Public Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2027

Primary Completion (Estimated)

March 1, 2029

Study Completion (Estimated)

August 1, 2030

Study Registration Dates

First Submitted

March 31, 2026

First Submitted That Met QC Criteria

March 31, 2026

First Posted (Actual)

April 7, 2026

Study Record Updates

Last Update Posted (Actual)

April 7, 2026

Last Update Submitted That Met QC Criteria

March 31, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H26093
  • K01AA032045 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Intervention 1

Subscribe